Haystack Oncology Competitors and Similar CompaniesClear all
Haystack Oncology's competitors and similar companies include Curie Therapeutics, Xencor, Allucent TX and NETRIS Pharma.
 Haystack Oncology Haystack Oncology is a company specializing in liquid biopsy solutions for the biopharma industry. |  Curie Therapeutics Curie Therapeutics is a company developing radiopharmaceuticals targeted at the treatment of solid tumors. |  Xencor Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. |  Allucent TX Allucent (also known as Pharm-Olam) is a contract research organization offering clinical research services (Phase I-IV) to the pharmaceutical, biotechnology, and medical device industries. |  NETRIS Pharma NETRIS Pharma is a clinical-stage immuno-oncology company that develops targeted therapies for the treatment of cancer. | |
Founding Date | Founding Date 2021 | Founding Date 2021 | Founding Date 1997 | Founding Date 1994 | Founding Date 2008 |
Type | Type Private | Type Private | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Baltimore, US HQ Hamburg, DE | Locations Woburn, US HQ | Locations Pasadena, US HQ San Diego, US | Locations Chicago, US HQ Scherpenheuvel Zichem, BE Sao Paulo, BR Montréal, CA Zagreb, HR Prague, CZ Paris, FR see more | Locations Lyon, FR HQ |
Employees | Employees 55 | Employees 844% increase | Employees 2604% increase | Employees 4831% decrease | Employees 19 |
Funding | |||||
Latest funding round | Latest funding round $ 56m (over 3 years ago) | Latest funding round $ 75m (over 4 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 56m | Total funding raised $ 75m | Total funding raised $ 108.4m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Curie Therapeutics
HQ
Woburn, US
Employees
84↑ 4% increase
Curie Therapeutics is a company developing radiopharmaceuticals targeted at the treatment of solid tumors.
View companyXencor
HQ
Pasadena, US
Employees
260↑ 4% increase
Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
View companyAllucent TX
HQ
Chicago, US
Allucent (also known as Pharm-Olam) is a contract research organization offering clinical research services (Phase I-IV) to the pharmaceutical, biotechnology, and medical device industries.
View companyNETRIS Pharma
HQ
Lyon, FR
Employees
19
NETRIS Pharma is a clinical-stage immuno-oncology company that develops targeted therapies for the treatment of cancer.
View company